Merck's Keytruda + Galectin's Belapectin (GR-MD-02): Thoughts On The Evidence
Seeking Alpha,
Summary I provide a basic overview of Galectin Therapeutics, and where it, and galectin-3 research, stands today.
Summary I provide a basic overview of Galectin Therapeutics, and where it, and galectin-3 research, stands today.
Summary Recent third-party research bodes well for GALT's GR-MD-02. GR-MD-02 reduces Myeloid Derived Suppressor Cell levels.